KR101913004B1 - Manufacturing method of fermented mulberry beverage using mycelia of chaga mushroom - Google Patents
Manufacturing method of fermented mulberry beverage using mycelia of chaga mushroom Download PDFInfo
- Publication number
- KR101913004B1 KR101913004B1 KR1020160161379A KR20160161379A KR101913004B1 KR 101913004 B1 KR101913004 B1 KR 101913004B1 KR 1020160161379 A KR1020160161379 A KR 1020160161379A KR 20160161379 A KR20160161379 A KR 20160161379A KR 101913004 B1 KR101913004 B1 KR 101913004B1
- Authority
- KR
- South Korea
- Prior art keywords
- present
- fermented
- weight
- product
- beverage
- Prior art date
Links
- 235000001674 Agaricus brunnescens Nutrition 0.000 title claims abstract description 29
- 235000013361 beverage Nutrition 0.000 title claims abstract description 22
- 238000004519 manufacturing process Methods 0.000 title claims abstract description 10
- 235000008708 Morus alba Nutrition 0.000 title abstract description 12
- 240000000249 Morus alba Species 0.000 title abstract description 12
- 235000021028 berry Nutrition 0.000 claims abstract description 5
- 238000000034 method Methods 0.000 claims description 14
- 239000000203 mixture Substances 0.000 claims description 13
- 238000000855 fermentation Methods 0.000 claims description 12
- 230000004151 fermentation Effects 0.000 claims description 12
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims description 9
- 244000241257 Cucumis melo Species 0.000 claims description 5
- 235000015510 Cucumis melo subsp melo Nutrition 0.000 claims description 5
- FJJCIZWZNKZHII-UHFFFAOYSA-N [4,6-bis(cyanoamino)-1,3,5-triazin-2-yl]cyanamide Chemical compound N#CNC1=NC(NC#N)=NC(NC#N)=N1 FJJCIZWZNKZHII-UHFFFAOYSA-N 0.000 claims description 5
- 230000003178 anti-diabetic effect Effects 0.000 claims description 5
- 239000004615 ingredient Substances 0.000 claims description 5
- 241000167854 Bourreria succulenta Species 0.000 claims description 4
- 235000017848 Rubus fruticosus Nutrition 0.000 claims description 4
- 244000078534 Vaccinium myrtillus Species 0.000 claims description 4
- 235000019693 cherries Nutrition 0.000 claims description 4
- 241001672694 Citrus reticulata Species 0.000 claims description 3
- 244000144730 Amygdalus persica Species 0.000 claims description 2
- 244000099147 Ananas comosus Species 0.000 claims description 2
- 235000007119 Ananas comosus Nutrition 0.000 claims description 2
- 241001444063 Aronia Species 0.000 claims description 2
- 235000004936 Bromus mango Nutrition 0.000 claims description 2
- 235000005979 Citrus limon Nutrition 0.000 claims description 2
- 244000131522 Citrus pyriformis Species 0.000 claims description 2
- 240000000560 Citrus x paradisi Species 0.000 claims description 2
- 235000002767 Daucus carota Nutrition 0.000 claims description 2
- 244000000626 Daucus carota Species 0.000 claims description 2
- 235000011511 Diospyros Nutrition 0.000 claims description 2
- 244000236655 Diospyros kaki Species 0.000 claims description 2
- 240000009088 Fragaria x ananassa Species 0.000 claims description 2
- 241000220225 Malus Species 0.000 claims description 2
- 235000011430 Malus pumila Nutrition 0.000 claims description 2
- 235000015103 Malus silvestris Nutrition 0.000 claims description 2
- 235000014826 Mangifera indica Nutrition 0.000 claims description 2
- 240000007228 Mangifera indica Species 0.000 claims description 2
- 235000018290 Musa x paradisiaca Nutrition 0.000 claims description 2
- 235000006040 Prunus persica var persica Nutrition 0.000 claims description 2
- 244000294611 Punica granatum Species 0.000 claims description 2
- 235000014360 Punica granatum Nutrition 0.000 claims description 2
- 235000014443 Pyrus communis Nutrition 0.000 claims description 2
- 240000001987 Pyrus communis Species 0.000 claims description 2
- 240000001890 Ribes hudsonianum Species 0.000 claims description 2
- 235000016954 Ribes hudsonianum Nutrition 0.000 claims description 2
- 235000001466 Ribes nigrum Nutrition 0.000 claims description 2
- 235000009184 Spondias indica Nutrition 0.000 claims description 2
- 235000003095 Vaccinium corymbosum Nutrition 0.000 claims description 2
- 235000017537 Vaccinium myrtillus Nutrition 0.000 claims description 2
- 235000009754 Vitis X bourquina Nutrition 0.000 claims description 2
- 235000012333 Vitis X labruscana Nutrition 0.000 claims description 2
- 240000006365 Vitis vinifera Species 0.000 claims description 2
- 235000014787 Vitis vinifera Nutrition 0.000 claims description 2
- 235000021029 blackberry Nutrition 0.000 claims description 2
- 235000021014 blueberries Nutrition 0.000 claims description 2
- 239000012141 concentrate Substances 0.000 claims description 2
- 239000001963 growth medium Substances 0.000 claims description 2
- 238000002156 mixing Methods 0.000 claims description 2
- 238000010298 pulverizing process Methods 0.000 claims description 2
- 239000003472 antidiabetic agent Substances 0.000 claims 2
- 208000016261 weight loss Diseases 0.000 claims 2
- 241000207199 Citrus Species 0.000 claims 1
- 235000016623 Fragaria vesca Nutrition 0.000 claims 1
- 235000011363 Fragaria x ananassa Nutrition 0.000 claims 1
- 241000132456 Haplocarpha Species 0.000 claims 1
- 235000007688 Lycopersicon esculentum Nutrition 0.000 claims 1
- 240000008790 Musa x paradisiaca Species 0.000 claims 1
- 244000172730 Rubus fruticosus Species 0.000 claims 1
- 240000003768 Solanum lycopersicum Species 0.000 claims 1
- 235000020971 citrus fruits Nutrition 0.000 claims 1
- 230000004580 weight loss Effects 0.000 claims 1
- 229930002877 anthocyanin Natural products 0.000 abstract description 12
- 235000010208 anthocyanin Nutrition 0.000 abstract description 12
- 239000004410 anthocyanin Substances 0.000 abstract description 12
- 150000004636 anthocyanins Chemical class 0.000 abstract description 12
- 239000000796 flavoring agent Substances 0.000 abstract description 6
- 235000019634 flavors Nutrition 0.000 abstract description 6
- 235000020510 functional beverage Nutrition 0.000 abstract description 3
- 235000013376 functional food Nutrition 0.000 abstract description 3
- 239000002075 main ingredient Substances 0.000 abstract description 2
- 230000003078 antioxidant effect Effects 0.000 description 18
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 description 10
- 239000000284 extract Substances 0.000 description 10
- 239000008103 glucose Substances 0.000 description 10
- 150000003254 radicals Chemical class 0.000 description 10
- KRKNYBCHXYNGOX-UHFFFAOYSA-N citric acid Chemical compound OC(=O)CC(O)(C(O)=O)CC(O)=O KRKNYBCHXYNGOX-UHFFFAOYSA-N 0.000 description 9
- 239000008280 blood Substances 0.000 description 8
- 210000004369 blood Anatomy 0.000 description 8
- 239000000243 solution Substances 0.000 description 7
- CIWBSHSKHKDKBQ-JLAZNSOCSA-N Ascorbic acid Chemical compound OC[C@H](O)[C@H]1OC(=O)C(O)=C1O CIWBSHSKHKDKBQ-JLAZNSOCSA-N 0.000 description 6
- OKKJLVBELUTLKV-UHFFFAOYSA-N Methanol Chemical compound OC OKKJLVBELUTLKV-UHFFFAOYSA-N 0.000 description 6
- 239000003963 antioxidant agent Substances 0.000 description 6
- 235000006708 antioxidants Nutrition 0.000 description 6
- 239000007788 liquid Substances 0.000 description 6
- 239000002609 medium Substances 0.000 description 6
- 239000000052 vinegar Substances 0.000 description 6
- 235000021419 vinegar Nutrition 0.000 description 6
- 238000002835 absorbance Methods 0.000 description 5
- 230000000694 effects Effects 0.000 description 5
- 239000000463 material Substances 0.000 description 5
- 235000018185 Betula X alpestris Nutrition 0.000 description 4
- 235000018212 Betula X uliginosa Nutrition 0.000 description 4
- 229930091371 Fructose Natural products 0.000 description 4
- 239000005715 Fructose Substances 0.000 description 4
- RFSUNEUAIZKAJO-ARQDHWQXSA-N Fructose Chemical compound OC[C@H]1O[C@](O)(CO)[C@@H](O)[C@@H]1O RFSUNEUAIZKAJO-ARQDHWQXSA-N 0.000 description 4
- 241000700159 Rattus Species 0.000 description 4
- 201000010099 disease Diseases 0.000 description 4
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 4
- 235000003599 food sweetener Nutrition 0.000 description 4
- 235000000346 sugar Nutrition 0.000 description 4
- 239000003765 sweetening agent Substances 0.000 description 4
- 238000012360 testing method Methods 0.000 description 4
- QTBSBXVTEAMEQO-UHFFFAOYSA-N Acetic acid Chemical compound CC(O)=O QTBSBXVTEAMEQO-UHFFFAOYSA-N 0.000 description 3
- ZZZCUOFIHGPKAK-UHFFFAOYSA-N D-erythro-ascorbic acid Natural products OCC1OC(=O)C(O)=C1O ZZZCUOFIHGPKAK-UHFFFAOYSA-N 0.000 description 3
- 229930003268 Vitamin C Natural products 0.000 description 3
- 238000010521 absorption reaction Methods 0.000 description 3
- 238000004458 analytical method Methods 0.000 description 3
- WQZGKKKJIJFFOK-VFUOTHLCSA-N beta-D-glucose Chemical compound OC[C@H]1O[C@@H](O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-VFUOTHLCSA-N 0.000 description 3
- 230000037396 body weight Effects 0.000 description 3
- 230000000052 comparative effect Effects 0.000 description 3
- 206010012601 diabetes mellitus Diseases 0.000 description 3
- HHEAADYXPMHMCT-UHFFFAOYSA-N dpph Chemical compound [O-][N+](=O)C1=CC([N+](=O)[O-])=CC([N+]([O-])=O)=C1[N]N(C=1C=CC=CC=1)C1=CC=CC=C1 HHEAADYXPMHMCT-UHFFFAOYSA-N 0.000 description 3
- 238000002474 experimental method Methods 0.000 description 3
- 235000013305 food Nutrition 0.000 description 3
- 235000011389 fruit/vegetable juice Nutrition 0.000 description 3
- 238000005259 measurement Methods 0.000 description 3
- HELXLJCILKEWJH-NCGAPWICSA-N rebaudioside A Chemical compound O([C@H]1[C@H](O)[C@@H](CO)O[C@H]([C@@H]1O[C@H]1[C@@H]([C@@H](O)[C@H](O)[C@@H](CO)O1)O)O[C@]12C(=C)C[C@@]3(C1)CC[C@@H]1[C@@](C)(CCC[C@]1([C@@H]3CC2)C)C(=O)O[C@H]1[C@@H]([C@@H](O)[C@H](O)[C@@H](CO)O1)O)[C@@H]1O[C@H](CO)[C@@H](O)[C@H](O)[C@H]1O HELXLJCILKEWJH-NCGAPWICSA-N 0.000 description 3
- 230000001953 sensory effect Effects 0.000 description 3
- 239000000126 substance Substances 0.000 description 3
- 235000019154 vitamin C Nutrition 0.000 description 3
- 239000011718 vitamin C Substances 0.000 description 3
- UFHFLCQGNIYNRP-UHFFFAOYSA-N Hydrogen Chemical compound [H][H] UFHFLCQGNIYNRP-UHFFFAOYSA-N 0.000 description 2
- 206010020772 Hypertension Diseases 0.000 description 2
- CSNNHWWHGAXBCP-UHFFFAOYSA-L Magnesium sulfate Chemical compound [Mg+2].[O-][S+2]([O-])([O-])[O-] CSNNHWWHGAXBCP-UHFFFAOYSA-L 0.000 description 2
- WCUXLLCKKVVCTQ-UHFFFAOYSA-M Potassium chloride Chemical compound [Cl-].[K+] WCUXLLCKKVVCTQ-UHFFFAOYSA-M 0.000 description 2
- 244000228451 Stevia rebaudiana Species 0.000 description 2
- TVXBFESIOXBWNM-UHFFFAOYSA-N Xylitol Natural products OCCC(O)C(O)C(O)CCO TVXBFESIOXBWNM-UHFFFAOYSA-N 0.000 description 2
- 239000013543 active substance Substances 0.000 description 2
- 230000032683 aging Effects 0.000 description 2
- 238000010171 animal model Methods 0.000 description 2
- 230000003579 anti-obesity Effects 0.000 description 2
- 150000001720 carbohydrates Chemical class 0.000 description 2
- 235000014633 carbohydrates Nutrition 0.000 description 2
- YTMNONATNXDQJF-UBNZBFALSA-N chrysanthemin Chemical compound [Cl-].O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@H]1OC1=CC2=C(O)C=C(O)C=C2[O+]=C1C1=CC=C(O)C(O)=C1 YTMNONATNXDQJF-UBNZBFALSA-N 0.000 description 2
- 235000013399 edible fruits Nutrition 0.000 description 2
- 239000001257 hydrogen Substances 0.000 description 2
- 229910052739 hydrogen Inorganic materials 0.000 description 2
- HEBKCHPVOIAQTA-UHFFFAOYSA-N meso ribitol Natural products OCC(O)C(O)C(O)CO HEBKCHPVOIAQTA-UHFFFAOYSA-N 0.000 description 2
- 229920001542 oligosaccharide Polymers 0.000 description 2
- 150000002482 oligosaccharides Chemical class 0.000 description 2
- 239000002245 particle Substances 0.000 description 2
- 239000001965 potato dextrose agar Substances 0.000 description 2
- 238000011084 recovery Methods 0.000 description 2
- 238000011282 treatment Methods 0.000 description 2
- LWIHDJKSTIGBAC-UHFFFAOYSA-K tripotassium phosphate Chemical compound [K+].[K+].[K+].[O-]P([O-])([O-])=O LWIHDJKSTIGBAC-UHFFFAOYSA-K 0.000 description 2
- 239000000811 xylitol Substances 0.000 description 2
- 235000010447 xylitol Nutrition 0.000 description 2
- HEBKCHPVOIAQTA-SCDXWVJYSA-N xylitol Chemical compound OC[C@H](O)[C@@H](O)[C@H](O)CO HEBKCHPVOIAQTA-SCDXWVJYSA-N 0.000 description 2
- 229960002675 xylitol Drugs 0.000 description 2
- BJEPYKJPYRNKOW-REOHCLBHSA-N (S)-malic acid Chemical compound OC(=O)[C@@H](O)CC(O)=O BJEPYKJPYRNKOW-REOHCLBHSA-N 0.000 description 1
- OWEGMIWEEQEYGQ-UHFFFAOYSA-N 100676-05-9 Natural products OC1C(O)C(O)C(CO)OC1OCC1C(O)C(O)C(O)C(OC2C(OC(O)C(O)C2O)CO)O1 OWEGMIWEEQEYGQ-UHFFFAOYSA-N 0.000 description 1
- 235000009434 Actinidia chinensis Nutrition 0.000 description 1
- 244000298697 Actinidia deliciosa Species 0.000 description 1
- 235000009436 Actinidia deliciosa Nutrition 0.000 description 1
- 108010011485 Aspartame Proteins 0.000 description 1
- PYIXHKGTJKCVBJ-UHFFFAOYSA-N Astraciceran Natural products C1OC2=CC(O)=CC=C2CC1C1=CC(OCO2)=C2C=C1OC PYIXHKGTJKCVBJ-UHFFFAOYSA-N 0.000 description 1
- NDVRQFZUJRMKKP-UHFFFAOYSA-N Betavulgarin Natural products O=C1C=2C(OC)=C3OCOC3=CC=2OC=C1C1=CC=CC=C1O NDVRQFZUJRMKKP-UHFFFAOYSA-N 0.000 description 1
- 235000002359 Betula platyphylla var japonica Nutrition 0.000 description 1
- 241001606229 Betula platyphylla var. japonica Species 0.000 description 1
- 235000010140 Betula sp Nutrition 0.000 description 1
- 206010006187 Breast cancer Diseases 0.000 description 1
- 208000026310 Breast neoplasm Diseases 0.000 description 1
- UXVMQQNJUSDDNG-UHFFFAOYSA-L Calcium chloride Chemical compound [Cl-].[Cl-].[Ca+2] UXVMQQNJUSDDNG-UHFFFAOYSA-L 0.000 description 1
- 229920000858 Cyclodextrin Polymers 0.000 description 1
- FBPFZTCFMRRESA-FSIIMWSLSA-N D-Glucitol Natural products OC[C@H](O)[C@H](O)[C@@H](O)[C@H](O)CO FBPFZTCFMRRESA-FSIIMWSLSA-N 0.000 description 1
- FBPFZTCFMRRESA-JGWLITMVSA-N D-glucitol Chemical compound OC[C@H](O)[C@@H](O)[C@H](O)[C@H](O)CO FBPFZTCFMRRESA-JGWLITMVSA-N 0.000 description 1
- 229920001353 Dextrin Polymers 0.000 description 1
- 239000004375 Dextrin Substances 0.000 description 1
- 239000004278 EU approved seasoning Substances 0.000 description 1
- 208000010228 Erectile Dysfunction Diseases 0.000 description 1
- 239000004386 Erythritol Substances 0.000 description 1
- UNXHWFMMPAWVPI-UHFFFAOYSA-N Erythritol Natural products OCC(O)C(O)CO UNXHWFMMPAWVPI-UHFFFAOYSA-N 0.000 description 1
- 239000001512 FEMA 4601 Substances 0.000 description 1
- 241000747105 Fuscoporia Species 0.000 description 1
- 239000004378 Glycyrrhizin Substances 0.000 description 1
- 241000123247 Inonotus Species 0.000 description 1
- GUBGYTABKSRVRQ-PICCSMPSSA-N Maltose Natural products O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@@H]1O[C@@H]1[C@@H](CO)OC(O)[C@H](O)[C@H]1O GUBGYTABKSRVRQ-PICCSMPSSA-N 0.000 description 1
- 240000004658 Medicago sativa Species 0.000 description 1
- 235000017587 Medicago sativa ssp. sativa Nutrition 0.000 description 1
- 241000699670 Mus sp. Species 0.000 description 1
- 240000005561 Musa balbisiana Species 0.000 description 1
- 240000002853 Nelumbo nucifera Species 0.000 description 1
- 235000006508 Nelumbo nucifera Nutrition 0.000 description 1
- 235000006510 Nelumbo pentapetala Nutrition 0.000 description 1
- 206010028980 Neoplasm Diseases 0.000 description 1
- 240000007594 Oryza sativa Species 0.000 description 1
- 235000007164 Oryza sativa Nutrition 0.000 description 1
- 239000001888 Peptone Substances 0.000 description 1
- 108010080698 Peptones Proteins 0.000 description 1
- IHPVFYLOGNNZLA-UHFFFAOYSA-N Phytoalexin Natural products COC1=CC=CC=C1C1OC(C=C2C(OCO2)=C2OC)=C2C(=O)C1 IHPVFYLOGNNZLA-UHFFFAOYSA-N 0.000 description 1
- HELXLJCILKEWJH-SEAGSNCFSA-N Rebaudioside A Natural products O=C(O[C@H]1[C@@H](O)[C@@H](O)[C@H](O)[C@@H](CO)O1)[C@@]1(C)[C@@H]2[C@](C)([C@H]3[C@@]4(CC(=C)[C@@](O[C@H]5[C@H](O[C@H]6[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO)O6)[C@@H](O[C@H]6[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO)O6)[C@H](O)[C@@H](CO)O5)(C4)CC3)CC2)CCC1 HELXLJCILKEWJH-SEAGSNCFSA-N 0.000 description 1
- QNVSXXGDAPORNA-UHFFFAOYSA-N Resveratrol Natural products OC1=CC=CC(C=CC=2C=C(O)C(O)=CC=2)=C1 QNVSXXGDAPORNA-UHFFFAOYSA-N 0.000 description 1
- 241001092459 Rubus Species 0.000 description 1
- 241000576755 Sclerotia Species 0.000 description 1
- 241001558929 Sclerotium <basidiomycota> Species 0.000 description 1
- 229910000831 Steel Inorganic materials 0.000 description 1
- ZSJLQEPLLKMAKR-UHFFFAOYSA-N Streptozotocin Natural products O=NN(C)C(=O)NC1C(O)OC(CO)C(O)C1O ZSJLQEPLLKMAKR-UHFFFAOYSA-N 0.000 description 1
- 229930006000 Sucrose Natural products 0.000 description 1
- CZMRCDWAGMRECN-UGDNZRGBSA-N Sucrose Chemical compound O[C@H]1[C@H](O)[C@@H](CO)O[C@@]1(CO)O[C@@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO)O1 CZMRCDWAGMRECN-UGDNZRGBSA-N 0.000 description 1
- LUKBXSAWLPMMSZ-OWOJBTEDSA-N Trans-resveratrol Chemical compound C1=CC(O)=CC=C1\C=C\C1=CC(O)=CC(O)=C1 LUKBXSAWLPMMSZ-OWOJBTEDSA-N 0.000 description 1
- 240000008866 Ziziphus nummularia Species 0.000 description 1
- 210000000683 abdominal cavity Anatomy 0.000 description 1
- 235000011054 acetic acid Nutrition 0.000 description 1
- 239000002253 acid Substances 0.000 description 1
- BJEPYKJPYRNKOW-UHFFFAOYSA-N alpha-hydroxysuccinic acid Natural products OC(=O)C(O)CC(O)=O BJEPYKJPYRNKOW-UHFFFAOYSA-N 0.000 description 1
- 230000003712 anti-aging effect Effects 0.000 description 1
- 239000000605 aspartame Substances 0.000 description 1
- 235000010357 aspartame Nutrition 0.000 description 1
- IAOZJIPTCAWIRG-QWRGUYRKSA-N aspartame Chemical compound OC(=O)C[C@H](N)C(=O)N[C@H](C(=O)OC)CC1=CC=CC=C1 IAOZJIPTCAWIRG-QWRGUYRKSA-N 0.000 description 1
- 229960003438 aspartame Drugs 0.000 description 1
- QVGXLLKOCUKJST-UHFFFAOYSA-N atomic oxygen Chemical compound [O] QVGXLLKOCUKJST-UHFFFAOYSA-N 0.000 description 1
- GUBGYTABKSRVRQ-QUYVBRFLSA-N beta-maltose Chemical compound OC[C@H]1O[C@H](O[C@H]2[C@H](O)[C@@H](O)[C@H](O)O[C@@H]2CO)[C@H](O)[C@@H](O)[C@@H]1O GUBGYTABKSRVRQ-QUYVBRFLSA-N 0.000 description 1
- 230000008033 biological extinction Effects 0.000 description 1
- 238000010241 blood sampling Methods 0.000 description 1
- 239000011449 brick Substances 0.000 description 1
- 239000000872 buffer Substances 0.000 description 1
- 239000001110 calcium chloride Substances 0.000 description 1
- 229910001628 calcium chloride Inorganic materials 0.000 description 1
- 235000011148 calcium chloride Nutrition 0.000 description 1
- 201000011510 cancer Diseases 0.000 description 1
- 229940041514 candida albicans extract Drugs 0.000 description 1
- 238000006243 chemical reaction Methods 0.000 description 1
- 239000003153 chemical reaction reagent Substances 0.000 description 1
- 235000015165 citric acid Nutrition 0.000 description 1
- 229910000365 copper sulfate Inorganic materials 0.000 description 1
- ARUVKPQLZAKDPS-UHFFFAOYSA-L copper(II) sulfate Chemical compound [Cu+2].[O-][S+2]([O-])([O-])[O-] ARUVKPQLZAKDPS-UHFFFAOYSA-L 0.000 description 1
- 238000012136 culture method Methods 0.000 description 1
- 238000012258 culturing Methods 0.000 description 1
- 230000007423 decrease Effects 0.000 description 1
- 230000003247 decreasing effect Effects 0.000 description 1
- 238000011161 development Methods 0.000 description 1
- 230000018109 developmental process Effects 0.000 description 1
- 235000019425 dextrin Nutrition 0.000 description 1
- 239000003085 diluting agent Substances 0.000 description 1
- 238000010790 dilution Methods 0.000 description 1
- 239000012895 dilution Substances 0.000 description 1
- 150000002016 disaccharides Chemical class 0.000 description 1
- 239000012153 distilled water Substances 0.000 description 1
- 230000008030 elimination Effects 0.000 description 1
- 238000003379 elimination reaction Methods 0.000 description 1
- 230000002708 enhancing effect Effects 0.000 description 1
- HELXLJCILKEWJH-UHFFFAOYSA-N entered according to Sigma 01432 Natural products C1CC2C3(C)CCCC(C)(C(=O)OC4C(C(O)C(O)C(CO)O4)O)C3CCC2(C2)CC(=C)C21OC(C1OC2C(C(O)C(O)C(CO)O2)O)OC(CO)C(O)C1OC1OC(CO)C(O)C(O)C1O HELXLJCILKEWJH-UHFFFAOYSA-N 0.000 description 1
- 235000019414 erythritol Nutrition 0.000 description 1
- UNXHWFMMPAWVPI-ZXZARUISSA-N erythritol Chemical compound OC[C@H](O)[C@H](O)CO UNXHWFMMPAWVPI-ZXZARUISSA-N 0.000 description 1
- 229940009714 erythritol Drugs 0.000 description 1
- 239000003925 fat Substances 0.000 description 1
- 235000019197 fats Nutrition 0.000 description 1
- 229930003935 flavonoid Natural products 0.000 description 1
- 150000002215 flavonoids Chemical class 0.000 description 1
- 235000017173 flavonoids Nutrition 0.000 description 1
- 235000011194 food seasoning agent Nutrition 0.000 description 1
- 230000007760 free radical scavenging Effects 0.000 description 1
- -1 free radicals Chemical class 0.000 description 1
- 235000015203 fruit juice Nutrition 0.000 description 1
- 235000001727 glucose Nutrition 0.000 description 1
- 150000004676 glycans Chemical class 0.000 description 1
- LPLVUJXQOOQHMX-UHFFFAOYSA-N glycyrrhetinic acid glycoside Natural products C1CC(C2C(C3(CCC4(C)CCC(C)(CC4C3=CC2=O)C(O)=O)C)(C)CC2)(C)C2C(C)(C)C1OC1OC(C(O)=O)C(O)C(O)C1OC1OC(C(O)=O)C(O)C(O)C1O LPLVUJXQOOQHMX-UHFFFAOYSA-N 0.000 description 1
- 229960004949 glycyrrhizic acid Drugs 0.000 description 1
- UYRUBYNTXSDKQT-UHFFFAOYSA-N glycyrrhizic acid Natural products CC1(C)C(CCC2(C)C1CCC3(C)C2C(=O)C=C4C5CC(C)(CCC5(C)CCC34C)C(=O)O)OC6OC(C(O)C(O)C6OC7OC(O)C(O)C(O)C7C(=O)O)C(=O)O UYRUBYNTXSDKQT-UHFFFAOYSA-N 0.000 description 1
- 235000019410 glycyrrhizin Nutrition 0.000 description 1
- LPLVUJXQOOQHMX-QWBHMCJMSA-N glycyrrhizinic acid Chemical compound O([C@@H]1[C@@H](O)[C@H](O)[C@H](O[C@@H]1O[C@@H]1C([C@H]2[C@]([C@@H]3[C@@]([C@@]4(CC[C@@]5(C)CC[C@@](C)(C[C@H]5C4=CC3=O)C(O)=O)C)(C)CC2)(C)CC1)(C)C)C(O)=O)[C@@H]1O[C@H](C(O)=O)[C@@H](O)[C@H](O)[C@H]1O LPLVUJXQOOQHMX-QWBHMCJMSA-N 0.000 description 1
- 235000012907 honey Nutrition 0.000 description 1
- FUKUFMFMCZIRNT-UHFFFAOYSA-N hydron;methanol;chloride Chemical compound Cl.OC FUKUFMFMCZIRNT-UHFFFAOYSA-N 0.000 description 1
- 230000003345 hyperglycaemic effect Effects 0.000 description 1
- 201000001421 hyperglycemia Diseases 0.000 description 1
- 201000001881 impotence Diseases 0.000 description 1
- 239000012535 impurity Substances 0.000 description 1
- 230000001939 inductive effect Effects 0.000 description 1
- 238000011081 inoculation Methods 0.000 description 1
- 229910000358 iron sulfate Inorganic materials 0.000 description 1
- BAUYGSIQEAFULO-UHFFFAOYSA-L iron(2+) sulfate (anhydrous) Chemical compound [Fe+2].[O-]S([O-])(=O)=O BAUYGSIQEAFULO-UHFFFAOYSA-L 0.000 description 1
- 229940069445 licorice extract Drugs 0.000 description 1
- 238000009630 liquid culture Methods 0.000 description 1
- 229910052943 magnesium sulfate Inorganic materials 0.000 description 1
- 235000019341 magnesium sulphate Nutrition 0.000 description 1
- 239000001630 malic acid Substances 0.000 description 1
- 235000011090 malic acid Nutrition 0.000 description 1
- 230000008774 maternal effect Effects 0.000 description 1
- 150000002772 monosaccharides Chemical class 0.000 description 1
- 229910052757 nitrogen Inorganic materials 0.000 description 1
- 235000015097 nutrients Nutrition 0.000 description 1
- 239000001301 oxygen Substances 0.000 description 1
- 229910052760 oxygen Inorganic materials 0.000 description 1
- 230000003071 parasitic effect Effects 0.000 description 1
- 235000019319 peptone Nutrition 0.000 description 1
- 239000000280 phytoalexin Substances 0.000 description 1
- 150000001857 phytoalexin derivatives Chemical class 0.000 description 1
- 229920001282 polysaccharide Polymers 0.000 description 1
- 239000005017 polysaccharide Substances 0.000 description 1
- 239000001103 potassium chloride Substances 0.000 description 1
- 235000011164 potassium chloride Nutrition 0.000 description 1
- 229910000160 potassium phosphate Inorganic materials 0.000 description 1
- 235000011009 potassium phosphates Nutrition 0.000 description 1
- 238000002360 preparation method Methods 0.000 description 1
- 238000003672 processing method Methods 0.000 description 1
- 235000018102 proteins Nutrition 0.000 description 1
- 108090000623 proteins and genes Proteins 0.000 description 1
- 102000004169 proteins and genes Human genes 0.000 description 1
- 239000003642 reactive oxygen metabolite Substances 0.000 description 1
- 235000019203 rebaudioside A Nutrition 0.000 description 1
- 230000003252 repetitive effect Effects 0.000 description 1
- 235000021283 resveratrol Nutrition 0.000 description 1
- 229940016667 resveratrol Drugs 0.000 description 1
- 235000009566 rice Nutrition 0.000 description 1
- 235000019204 saccharin Nutrition 0.000 description 1
- CVHZOJJKTDOEJC-UHFFFAOYSA-N saccharin Chemical compound C1=CC=C2C(=O)NS(=O)(=O)C2=C1 CVHZOJJKTDOEJC-UHFFFAOYSA-N 0.000 description 1
- 229940081974 saccharin Drugs 0.000 description 1
- 239000000901 saccharin and its Na,K and Ca salt Substances 0.000 description 1
- HFHDHCJBZVLPGP-UHFFFAOYSA-N schardinger α-dextrin Chemical compound O1C(C(C2O)O)C(CO)OC2OC(C(C2O)O)C(CO)OC2OC(C(C2O)O)C(CO)OC2OC(C(O)C2O)C(CO)OC2OC(C(C2O)O)C(CO)OC2OC2C(O)C(O)C1OC2CO HFHDHCJBZVLPGP-UHFFFAOYSA-N 0.000 description 1
- 238000004062 sedimentation Methods 0.000 description 1
- 239000008159 sesame oil Substances 0.000 description 1
- 235000011803 sesame oil Nutrition 0.000 description 1
- 239000007974 sodium acetate buffer Substances 0.000 description 1
- 239000007787 solid Substances 0.000 description 1
- 239000000600 sorbitol Substances 0.000 description 1
- 235000010356 sorbitol Nutrition 0.000 description 1
- 229960002920 sorbitol Drugs 0.000 description 1
- 239000010959 steel Substances 0.000 description 1
- 235000013948 strawberry juice Nutrition 0.000 description 1
- ZSJLQEPLLKMAKR-GKHCUFPYSA-N streptozocin Chemical compound O=NN(C)C(=O)N[C@H]1[C@@H](O)O[C@H](CO)[C@@H](O)[C@@H]1O ZSJLQEPLLKMAKR-GKHCUFPYSA-N 0.000 description 1
- 229960001052 streptozocin Drugs 0.000 description 1
- 239000005720 sucrose Substances 0.000 description 1
- 150000005846 sugar alcohols Chemical class 0.000 description 1
- 238000010998 test method Methods 0.000 description 1
- 239000011573 trace mineral Substances 0.000 description 1
- 235000013619 trace mineral Nutrition 0.000 description 1
- 239000012138 yeast extract Substances 0.000 description 1
- NWONKYPBYAMBJT-UHFFFAOYSA-L zinc sulfate Chemical compound [Zn+2].[O-]S([O-])(=O)=O NWONKYPBYAMBJT-UHFFFAOYSA-L 0.000 description 1
- 229910000368 zinc sulfate Inorganic materials 0.000 description 1
- 229960001763 zinc sulfate Drugs 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L2/00—Non-alcoholic beverages; Dry compositions or concentrates therefor; Their preparation
- A23L2/38—Other non-alcoholic beverages
- A23L2/382—Other non-alcoholic beverages fermented
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2002/00—Food compositions, function of food ingredients or processes for food or foodstuffs
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2200/00—Function of food ingredients
- A23V2200/30—Foods, ingredients or supplements having a functional effect on health
- A23V2200/332—Promoters of weight control and weight loss
Abstract
본 발명은 뽕나무 열매인 오디를 주재료로 하는 건강기능성 음료 및 이의 제조방법에 관한 것으로서, 본 발명에 의해 제조된 오디의 차가버섯 균사체 발효물을 포함하는 오디음료는 안토시아닌 함량이 높아 항산화 효능이 우수할 뿐만 아니라 풍미와 맛이 개선되어 건강기능성 식품으로 유용하게 활용될 수 있다.The present invention relates to a health functional beverage containing mulberry berries as a main ingredient and a process for preparing the same. The odd beverage containing the fermented mushroom mycelia of the present invention produced by the present invention has a high anthocyanin content, In addition, the flavor and taste can be improved and useful as health functional food.
Description
본 발명은 뽕나무 열매인 오디를 주재료로 하는 건강기능성 음료 및 이의 제조방법에 관한 것으로서 보다 구체적으로 오디의 차가버섯 균사체 발효를 이용한 고기능성 음료 및 이의 제조방법에 관한 것이다.The present invention relates to a health functional beverage having mulberry berries as a main ingredient, and a method for preparing the same, and more specifically, to a high-function beverage using mulberry mycelium fermentation and a process for producing the same.
오디(Mulberry)는 뽕나무과에 속하는 낙엽교목인 뽕나무(Morus alba L.)의 열매로서 다량의 과당과 포도당을 함유하고 있을 뿐만 아니라 안토시아닌, 플라보노이드 및 파이토알렉신과 같은 여러 유용한 생리활성물질을 함유하고 있어 다양한 효능을 나타내는 것으로 확인되고 있다. 특히 오디는 여러 베리류에 많이 포함되어 있는 안토시아닌 계열의 물질인 시아니딘-3-글루코시드(cyanidin 3-glucoside, C3G)를 높은 함량으로 포함하고 있어 항산화 및 노화억제 효과가 우수한 것으로 알려져 있으며, 당뇨병성 방광병증(대한민국 공개특허공보 제10-2013-0112592호), 당뇨병성 발기부전(대한민국 공개특허공보 제10-2013-0025990호), 유방암(대한민국 공개특허공보 제10-2016-0065304호) 등의 질병에 대해서도 질병 개선 효과를 나타내는 것으로 보고되고 있다.Mulberry is a fruit of mulberry (Morus alba L.) which is a deciduous tree belonging to Morus alba, and contains not only a large amount of fructose and glucose but also various useful physiologically active substances such as anthocyanin, flavonoid and phytoalexin Has been shown to exhibit efficacy. In particular, it is known that Audi contains high content of cyanidin-3-glucoside (C3G), an anthocyanin substance contained in many berries, and is known to have excellent antioxidative and anti-aging effects. (Korean Patent Laid-Open Publication No. 10-2013-0112592), diabetic erectile dysfunction (Korean Patent Laid-Open Publication No. 10-2013-0025990), breast cancer (Korean Patent Laid-Open No. 10-2016-0065304) It has been reported that the disease is also effective in improving the disease.
이러한 오디의 유용성분에 대한 연구결과를 바탕으로 오디 또는 그 성분을 활용한 여러 기능성 식품들이 개발되고 있는데, 가령 대한민국 등록특허 제 10-0920334호는 뽕나무 열매인 오디를 마쇄한 후 알콜발효 및 초산발효시켜 제조한 '오디식초와 그 제조방법 및 오디식초를 함유한 기능성 음료'를, 대한민국 공개특허공보 제 10-2013-0059657호는 오디 과즙, 발효 식초, 올리고당, 정제수를 주성분으로 포함하며, 사과 농축액, 구연산, 벌꿀, 비타민 C, 연잎추출물, 오디향 및 스테비아 추출물을 소량 포함하는 '오디발효 식초 음료와 그 제조 방법'을, 대한민국 등록특허 제 10-1276094호는 오디를 갈아 오디즙을 만들고, 다시 이를 농축한 농축액을 사용함에 의해 안토시아닌 및 레스베라트롤을 다량 함유하고 있는 '항산화 기능성 오디 음료'를 각각 개시하고 있다.Based on the results of studies on the useful components of such an audi, a variety of functional foods utilizing the audi or its components have been developed. For example, Korean Patent No. 10-0920334 discloses a method for fermenting alfalfa, Korean Patent Laid-Open Publication No. 10-2013-0059657 discloses an edible vinegar which is prepared by a method comprising the steps of: preparing an edible vinegar, a method for producing the edible vinegar, and a functional beverage containing the edible vinegar; and Korean Patent Publication No. 10-2013-0059657 disclosing an edible vinegar comprising fermented vinegar, oligosaccharide, , 'Citric acid, honey, vitamin C, lotus leaf extract, oodine and stevia extract, and a preparation method thereof. Korean Patent No. 10-1276094 discloses a process for producing oodi juice, And an " antioxidant functional < RTI ID = 0.0 > odi < / RTI > beverage ", which contains a large amount of anthocyanin and resveratrol by using a concentrated liquid.
그러나, 상기와 같은 방법은 오디가 자체적으로 갖는 기본적인 항산화 활성에만 의존하여 보다 강력한 항산화 소재를 찾는 시장에 수요에 부합하지 못하는 한계가 있었다. However, the above-mentioned method has a limitation in that it can not meet the demand for a market in which a more powerful antioxidant material is sought depending on the basic antioxidant activity of Odi itself.
이에 본 발명자들은 오디를 이용한 오디음료 개발에 있어서 오디가 갖는 항산화 능력을 더욱 증대시키기 위하여 오디의 여러 생리활성물질 함량을 높이면서 향미와 맛이 향상된 오디음료를 개발하고자 연구한 끝에 본 발명을 완성하게 되었다.Accordingly, the present inventors have completed the present invention in order to develop an audi beverage having improved flavor and taste while enhancing the content of various physiologically active substances of Audi in order to further enhance the antioxidative ability of the audi in the development of the audi drink using the audi .
본 발명의 목적은 오디 생과물에 차가버섯 균사체를 접종하여 발효시킴으로써 당 함량을 낮추면서도 여러 기능성 성분들의 함량을 증가시킨 오디음료 및 이의 제조방법을 제공하는 것이다.It is an object of the present invention to provide an edible beverage having an increased content of various functional ingredients while lowering the sugar content by fermenting the mushroom mycelium by inoculating it with water and water, and a process for producing the same.
상기 목적을 달성하기 위하여, 본 발명은 (a) 오디 생과를 동결건조시킨 후 분쇄하여 분쇄물을 생성하는 단계; (b) 상기 오디 분쇄물 대비 물을 10~30 중량% 첨가하여 혼합물을 생성하는 단계; (c) 상기 혼합물에 차가버섯 균사체 배양액을 접종하고 발효시켜 발효물을 생성하는 단계; 및 (d) 상기 발효물에 부재료를 넣어 혼합하는 단계를 포함하는 오디음료의 제조방법를 포함하는 오디음료의 제조방법을 제공한다.In order to accomplish the above object, the present invention provides a method for producing a pulverized product, comprising the steps of: (a) lyophilizing and pulverizing an oder seed to produce a pulverized product; (b) adding 10 to 30% by weight of water to the ground product to produce a mixture; (c) inoculating the mixture with a culture solution of a mushroom mycelium to produce a fermented product; And (d) adding a sub ingredient to the fermented product to prepare an edible beverage.
본 발명자들은 오디의 항산화 활성 등 기능성에 주목하여 이를 더욱 개선시키기 위해 예의 연구노력한 결과, 차가버섯 균사체 배양액으로 오디를 발효시키는 경우, 발효산물의 안토시아닌 함량이 증가하고, 항산화, 고혈압 개선, 항당뇨 효과가 개선되는 것을 확인하고, 본 발명을 완성하였다. The present inventors paid attention to the functionalities such as the antioxidant activity of the mulberry and found that when the mulberry mushroom culture broth is fermented with the mulberry mycelium culture liquid, the anthocyanin content of the fermented product is increased and the antioxidant, hypertension improvement, And the present invention has been completed.
본 발명에서 사용되는 차가버섯은 이노노투스 오블리쿠아(Inonotus obliqua) 또는 퍼스코포리아 오블리쿠아(Fuscoporia obliqua)이다. 러시아에서는 차가(Chaga)로 불리우며, 일본에서는 카바노아나타케로 불린다. 균핵 형태는 표면이 검고, 종횡으로 균열이 많으며, 내부는 황갈색이다. 균사가 조밀하게 모여 만드는 딱딱한 덩어리인 균핵이 주로 약용으로 사용하는 부분이다. 균핵의 직경은 10 내지 20cm 정도로 대형이다. 자실체의 두께는 2 내지 8mm 정도이고 전면에 관공이 있으며 강모체는 여러 개이다. 차가버섯은 자작나무류(Betula sp.), 특히 자작나무(Betula platyphylla var. japonica)에서 발생한다. 자작나무류에 검은 암 덩어리처럼 붙어 있다가 그 덩어리가 점차 커지면서 자작나무류가 점차 죽어가는 반활물, 반사물 기생버섯이다.The mushroom used in the present invention is Inonotus obliqua or Fuscoporia obliqua . In Russia, it is called Chaga, and in Japan it is called Kabano anatake. The sclerotium form is black on the surface, has many longitudinal and lateral cracks, and has a tan inside. Sclerotia, a firm mass of hyphae gathered densely, is mainly used for medicinal purposes. The diameter of scleroti is as large as 10 to 20 cm. The thickness of the fruiting body is about 2 to 8 mm, there is a hole in the front, and there are several steel bodies. The mushroom occurs in birch (Betula sp.), Especially in birch (Betula platyphylla var. Japonica). It is a semi-active, reflective parasitic mushroom whose birch trees are gradually dying as they are attached to a birch tree like a black cancer.
본 발명에서 사용되는 용어 '발효물'이란, 차가버섯이 성장할 수 있도록, 오디 착즙액, 생과액, 이들의 희석액 또는 추출액 등을 배지로 하여 차가버섯 균사체를 접종하고 배양한 배양물로부터 수득한 배양결과물을 의미한다. 본 발명의 실시예에서는 차가버섯 균사체 배양액으로 오디 분쇄물을 발효시키는 경우, 발효산물의 안토시아닌 함량이 증가하고, 항산화, 고혈압 개선, 항당뇨 효과가 개선되는 것을 확인한 바 있다. The term " fermented product " used in the present invention means a fermented product obtained by inoculating a mycelia of Mycorrhizae with a culture solution obtained by cultivating a mushroom mycelium with a medium such as a juice solution, a solution, a diluent or an extract thereof, It means the result. In the examples of the present invention, it has been confirmed that the anthocyanin content of the fermented product is increased and the antioxidant, hypertension improvement, and antidiabetic effect are improved when fermented product is pulverized with the mushroom mycelia culture solution.
본 발명에서 이용되는 차가버섯은 자연산 또는 인공배양에 의한 것이다. 인공배양은 액체배양법과 고체배양법을 모두 사용할 수 있다. 액체배양은 차가버섯 균주를 포도당, 펩톤, 효모추출액을 필수 성분으로 포함하는 액체배지에서 3 내지 30일간 배양하여 균사체를 얻는다. 배지에는 상기 필수 성분 외에 인산 제2칼륨, 황산마그네슘, 염화칼슘 등의 무기물과 황산철, 황산아연, 황산구리 등의 미량원소를 첨가하여 균사체의 발육을 돕도록 할 수 있다. 배지의 pH는 5~7, 온도는 20℃ 내지 30℃ 정도로 조절한다. 고체배양법으로는 원목배양법을 이용하는데, 차가버섯 균주를 원목에서 배양하여 자실체를 얻는다, 원목배양을 위한 종균제조를 위하여 원목 톱밥에 미강을 첨가한 배지에, 맥아추출물배지에서 배양된 차가버섯균사를 떼어내 접종하고 20 내지 30 일간 20℃ 내지 30℃ 암 조건하에서 배양한다.The mushroom used in the present invention is obtained by natural or artificial cultivation. Both artificial culture and liquid cultivation can be used. Liquid culture is carried out by culturing the mushroom strain in a liquid medium containing glucose, peptone and yeast extract as essential components for 3 to 30 days to obtain a mycelium. In addition to the essential components described above, inorganic substances such as potassium phosphate, magnesium sulfate, and calcium chloride, and trace elements such as iron sulfate, zinc sulfate, and copper sulfate can be added to the culture medium to help develop the mycelium. The pH of the medium is adjusted to 5 to 7, and the temperature is adjusted to about 20 to 30 ° C. In solid culture method, roasted mushroom strain is cultivated in a log to obtain fruiting body. In order to prepare a seed for the roots cultivation, roasted mushroom mycelium cultured in a malt extract medium is added to a medium containing rice bran And inoculated and cultured for 20 to 30 days at 20 占 폚 to 30 占 폚 under dark conditions.
본 발명의 일실시예에 있어서, 상기 발효는 발효온도 20~30℃, 및 발효시간 7 일 내지 21 일 동안 수행하는 것이 생성되는 상기 발효물의 항산화 활성, 항당뇨 활성, 및 항비만 활성 증가에 바람직하나, 이에 제한되는 것은 아니다. In one embodiment of the present invention, the fermentation is preferably carried out at a fermentation temperature of 20 to 30 ° C and a fermentation time of 7 days to 21 days to produce an antioxidant activity, an anti-diabetic activity and an anti-obesity activity But is not limited thereto.
본 발명의 일실시예에 있어서, 상기 차가버섯 균사체 배양액은 상기 (b)단계의 혼합물 대비 10 중량%로 접종하는 것이 바람직하나, 이에 제한되는 것은 아니다. In one embodiment of the present invention, the culture of the mycelia of mycelia of the mushroom is preferably inoculated at 10 wt% of the mixture of the step (b), but the present invention is not limited thereto.
본 발명의 일실시예에 있어서, 상기 발효 단계의 조건은 발효온도 20~30℃, 발효시간 7일 내지 21일 인 것이 바람직하나 이에 제한되는 것은 아니다. In one embodiment of the present invention, the fermentation temperature is 20 to 30 ° C and the fermentation time is 7 to 21 days, but the present invention is not limited thereto.
본 발명의 일실시예에 있어서, 상기 (d)단계의 부재료에는 아로니아, 사과, 감, 블루베리, 블랙베리, 블랙커런트, 복분자, 석류, 포도, 배, 복숭아, 바나나, 딸기, 토마토, 당근, 자두, 매실, 앵두, 다래, 머루, 키위, 참외, 귤, 오렌지, 자몽, 귤, 멜론, 체리, 멜론, 블랙수퍼베리, 망고, 레몬, 파인애플 등의 원료과실 또는 그 농축액이 포함될 수 있으나 이에 제한되는 것은 아니다. In one embodiment of the present invention, the material of step (d) includes at least one selected from the group consisting of Aronia, apple, persimmon, blueberry, blackberry, black currant, brambles, pomegranate, grape, pear, peach, banana, strawberry, Or fruit juice or concentrate thereof such as plum, plum, cherry, plum, marjor, kiwi, melon, tangerine, orange, grapefruit, mandarin, melon, cherry, melon, black super berry, mango, lemon and pineapple But is not limited to.
또한, 본 발명은 상기 제조방법에 의해 제조된 오디음료를 제공한다. In addition, the present invention provides an edible drink produced by the above-described method.
본 발명의 오디 음료는 상기 차가버섯 균사체 오디 발효물 및 상기 부재료 이외에 식품 제조 시에 통상적으로 첨가되는 성분을 포함한다. 예를 들어, 단백질, 탄수화물, 지방, 영양소, 조미제 및 감미제를 포함한다. 상술한 탄수화물의 예는 모노사카라이드, 예를 들어, 포도당, 과당 등; 디사카라이드, 예를 들어 말토스, 슈크로스, 올리고당 등; 및 폴리사카라이드, 예를 들어 덱스트린, 사이클로덱스트린 등과 같은 통상적인 당 및 자일리톨, 소르비톨, 에리트리톨 등의 당알콜이다. 감미제로서 천연 감미제[타우마틴, 스테비아 추출물(예를 들어 레바우디오시드 A, 글리시리진 등)] 및 합성 감미제(사카린, 아스파르탐 등)를 사용할 수 있다. 예컨대, 본 발명의 식품 조성물이 드링크제로 제조되는 경우에는 본 발명의 유효성분 이외에 구연산, 액상과당, 설탕, 포도당, 초산, 사과산, 과즙, 두충 추출액, 대추 추출액, 감초 추출액 등을 추가로 포함시킬 수 있다.The edible beverage of the present invention includes the fermented mushroom mycelium fermented product and components other than the above-mentioned ingredients, which are ordinarily added in food production. For example, proteins, carbohydrates, fats, nutrients, seasonings and sweeteners. Examples of the above-mentioned carbohydrates are monosaccharides such as glucose, fructose, and the like; Disaccharides such as maltose, sucrose, oligosaccharides and the like; And polysaccharides such as dextrin, cyclodextrin and the like, and sugar alcohols such as xylitol, sorbitol and erythritol. As a sweetening agent, a natural sweetening agent (e.g., tau Martin, stevia extract (e.g., rebaudioside A, glycyrrhizin)) and a synthetic sweetener (saccharin, aspartame, etc.) may be used. For example, when the food composition of the present invention is prepared as a drink, it may further contain citric acid, liquid fructose, sugar, glucose, acetic acid, malic acid, juice, mulberry extract, jujube extract, licorice extract, have.
본 발명의 바람직한 양태에 따르면, 본 발명의 상기 오디음료는 pH가 3.0~4.3, 총산의 함량이 0.3~1.4%, 당도가 50~62 브릭스이나, 이에 제한되는 것은 아니다.According to a preferred embodiment of the present invention, the edible beverage of the present invention has a pH of 3.0 to 4.3, a total acid content of 0.3 to 1.4% and a sugar content of 50 to 62 Bricks, but is not limited thereto.
본 발명의 오디음료는 상술한 본 발명의 오디음료의 제조방법에 의해 제조되는 것으로서, 이 둘 사이에 공통된 내용은 반복 기재에 따른 명세서의 과도한 복잡성을 피하기 위하여, 그 기재를 생략한다.The edible beverage of the present invention is produced by the above-described method for producing an edible beverage of the present invention, and the description common to both of them is omitted in order to avoid excessive complexity of the specification according to the repetitive description.
본 발명에 의해 제조된 오디의 차가버섯 균사체 발효물을 포함하는 오디음료는 안토시아닌 함량이 높아 항산화 및 항비만 효능이 우수할 뿐만 아니라 풍미와 맛이 개선되어 건강기능성 식품으로 널리 이용될 수 있다.The edible beverage comprising the fermented product of the mushroom mycelia produced according to the present invention has high antioxidant and anti-obesity effects due to its high anthocyanin content, and can be widely used as a health functional food with improved flavor and taste.
이하에서는 실시예를 통하여 본 발명을 더욱 상세히 설명하고자 한다. 다만, 이들 실시예는 오로지 본 발명을 예시하기 위한 것으로서, 본 발명의 범위가 이들 실시예에 의해 제한되는 것으로 해석되지는 않는다 할 것이다.Hereinafter, the present invention will be described in more detail with reference to Examples. It should be understood, however, that these examples are for illustrative purposes only and are not to be construed as limiting the scope of the present invention.
<실시예 1> ≪ Example 1 >
오디 열매 분쇄물의 제조Manufacture of Oudy fruit pulverized material
오디 열매를 약 -30℃의 온도로 30분간 급냉시킨 후 분쇄기로 분쇄한 후 분쇄물을 체(Sieve)로 걸러 일정 크기(약 45 mesh) 이하의 입자로 선별하였다. 위 분쇄물과 분쇄물 대비 물 20 중량%를 혼합한 후 분쇄물의 입자가 고르게 섞이도록 교반하였다. The seeds of the oak were quenched at a temperature of about -30 ° C for 30 minutes, and then pulverized by a pulverizer. The pulverized material was sieved and sorted into particles having a predetermined size (about 45 mesh) or less. 20% by weight of water was mixed with the crushed product and the crushed product, and the crushed product was agitated so that the particles of the crushed product were evenly mixed.
그 후, 분쇄물을 살균 및 여과한 후 차가버섯 균사체 배양액과 혼합하였다.Thereafter, the pulverized material was sterilized and filtered, and then mixed with the mushroom mycelial culture liquid.
<실시예 2>≪ Example 2 >
차가버섯 균사체 배양액의 제조Production of mycelia culture
차가버섯 균주를 PDA(potato dextrose agar) 배지에 접종하여, 30℃ 온도에서 7주간 배양하여 차가버섯 균사체를 준비하였다.The mushroom strain was inoculated on a PDA (potato dextrose agar) medium and cultured at 30 ° C. for 7 weeks to prepare a mushroom mycelium.
<실시예 3>≪ Example 3 >
차가버섯 균사체 오디 Carrot mycelium mycelium 발효물Fermentation product 및 이를 이용한 오디음료의 제조 And production of an audi beverage using the same
상기 실시예1의 오디 열매 추출액과 실시예 2의 차가버섯 균사체를 혼합한 후 25℃에서 14일 동안 발효시킨 후 불순물을 제거하여 차가버섯 균사체 오디 발효물을 제조하였다. After mixing the extract of the sesame oil of Example 1 and the mushroom mycelium of Example 2, the mixture was fermented at 25 ° C for 14 days, and the impurities were removed to prepare a fermented mushroom mycelium fermented product.
상기 오디 발효물 7 중량%, 자일리톨 1 중량 %, 결정과당(73 Brix) 7 중량 %, 구연산 0.3 중량 % 에 증류수를 가하여 100 ml로 정용하였다. 이후 탄산수를 1 중량 % 추가하고, 이를 교반, 혼합한 후 병에 주입하고 80℃에서 30분간 살균한 후 냉각하여 본 발명의 오디음료를 제조하였다.Distilled water was added to 7% by weight of the above-mentioned edible fermented product, 1% by weight of xylitol, 7% by weight of fructose (73 Brix) and 0.3% by weight of citric acid, and the mixture was adjusted to 100 ml. Subsequently, 1% by weight of carbonated water was added, and the mixture was stirred and mixed. The mixture was then injected into a bottle, sterilized at 80 ° C for 30 minutes, and cooled to prepare an audi beverage of the present invention.
또한, 상기 차가버섯 균사체로 발효하지 않은 오디를 이용한 음료를 비교예로 사용하였다. In addition, a beverage using an edible mushroom which was not fermented by the mushroom mycelium was used as a comparative example.
<실시예 4><Example 4>
오디 Audi 발효물의Fermented 안토시아닌 함량 분석 Anthocyanin content analysis
상기 실시예 3에서 제조된 오디 발효물의 안토시아닌 함량은 Wrolstad 등 (2001)에 의한 pH differential method에 의하여 분석하였다. 상기 실시예에서 제조된 오디 발효물 3 g 에 0.5 % HCL-methanol 30 mL를 가하여 vortex mixer로 혼합하여 잘 섞은 후 24 시간 동안 실온의 암소에서 방치하여 추출하였다. 추출액은 여과지(Whattman No.2)로 여과한 후 각 추출물 0.5 mL에 0.025 M potassium chloride buffer(pH 1.0)와 0.4 M sodium acetate buffer(pH 4.5)를 가하여 최종 부피를 5 mL로 한 다음 분광광도계(HP-8452A Diode Array Spectrophotometer, Hewlett Packard)로 535㎚에서 흡광도를 측정하였다. 측정된 값을 이용하여 다음의 식에 대입하여 총 안토시아닌의 함량을 계산하였으며(Fuleke 등 1968, 전순실 등 2001, 박성준 등 1994) 총 3회 반복 측정하여 그 평균값을 구하였다.The anthocyanin content of the edible fermented product prepared in Example 3 was analyzed by the pH differential method according to Wrolstad et al. (2001). 30 g of 0.5% HCl-methanol was added to 3 g of the edible fermented product prepared in the above example, and the mixture was mixed with a vortex mixer. The mixture was left for 24 hours at room temperature in a dark place. The extract was filtered with a filter paper (Whattman No. 2), and 0.5 mL of each extract was adjusted to a final volume of 5 mL by adding 0.025 M potassium chloride buffer (pH 1.0) and 0.4 M sodium acetate buffer (pH 4.5) HP-8452A Diode Array Spectrophotometer, Hewlett Packard) at 535 nm. The total anthocyanin content was calculated by substituting the measured values into the following equation (Fuleke et al., 1968;
총 안토시아닌 함량 (㎎) = O.D × 200/W × 100 × 1/65.1Total anthocyanin content (mg) = O. D × 200 / W × 100 × 1 / 65.1
(O.D = 흡광도, W = 시료의 무게(g), 200 = 희석배수, 65.1 = 흡광계수)(O.D. = absorbance, W = weight of sample (g), 200 = dilution factor, 65.1 = extinction coefficient)
그 결과 오디 발효물의 안토시아닌 함량은 1.78%(w/w)로 발효처리하지 않은 추출물의 2배 정도 증가된 값으로 측정되었다.As a result, the anthocyanin content of the edible fermented product was 1.78% (w / w), which was twice as much as that of the non - fermented extract.
<실시예 5>≪ Example 5 >
오디 Audi 발효물의Fermented 항산화 효과 분석 Antioxidant effect analysis
상기 실시예 3에 따라 제조한 본 발명의 오디 발효물의 항산화 효과는 Blois의 방법에 준하여 각 시료에 2,2-diphenyl-1-picryhydrazyl(DPPH)에 대한 수소공여 효과로 측정하였다. 각각의 시료에 80% 메탄올로 녹여 최종농도를 10ug/mL, 100ug/mL 및 1000ug/mL로 하였다. 일정 농도의 시료1mL에 0.2mM DPPH용액(99% methanol)을 1mL 가하고, 10초 동안 혼합하여 37℃에서 30분간 반응시켰다. 이 반응액을 분광광도계(CARY 50 BIO, VARIAN, USA)를 사용하여 517nm에서 흡광도를 측정하였고, 전자공여능은 다음과 같은 계산식에 의해 계산하였다.The antioxidant activity of the fermented product of the present invention prepared in Example 3 was measured by hydrogen donating effect on 2,2-diphenyl-1-picryhydrazyl (DPPH) in each sample according to the Blois method. Each sample was dissolved in 80% methanol to give final concentrations of 10 ug / mL, 100 ug / mL and 1000 ug / mL. 1 mL of a 0.2 mM DPPH solution (99% methanol) was added to 1 mL of a constant concentration, mixed for 10 seconds, and reacted at 37 DEG C for 30 minutes. The absorbance of the reaction solution was measured at 517 nm using a spectrophotometer (CARY 50 BIO, VARIAN, USA). The electron donating ability was calculated by the following equation.
*전자공여능(%)=[1-(시료첨가구의 [0076] 흡광도/무첨가구의 흡광도)]×100* Electron donating ability (%) = [1- (absorbance of sample addition sphere / absorbance of no added sphere)] × 100
자유라디칼은 노화와 질병의 원인 중의 하나이다. 자유라디칼은 적어도 한쌍의 짝을 짓지 않은 전자를 포함하는 것을 말하며, 원자 및 분자는 기본적으로 어떤 물질과 전자를 공유하여 안정화되려고 하며, 생체 내에 수많은 자유라디칼 등 활성산소 종을 생성하게 한다. 이들 활성 산소 종은 각종 성인병과 노화를 일으킨다. 따라서 자유 라디칼을 제거 할 수 있는 능력을 측정함으로서 항산화력을 측정할 수 있다. 자유 라디칼 소거능 측정에 사용되는 2,2-diphenyl-1-picryhydrazyl(DPPH)는 짙은 자주색을 나타내며 그 자체가 질소 중심의 라디칼로서 라디칼 전자의 비 편재화에 의해 안정화된 상태로 존재한다. 또한 비교적 안정할 라디칼은 갖고 있으며 그것의 흡수 전자에 의해 516nm 부근에서 흡수 극대를 나타내는데 전자 또는 수소를 받으면 517nm 부근에서 흡광도가 감소하며 다시 산화되기 어렵다. 따라서 라디칼을 환원시키거나 상쇄시키는 능력이 크다면 높은 항산화 활성 및 활성산소를 비롯한 다른 라디칼에 대한 높은 제거 활성을 기대 할 수 있기 때문에 특정 물질의 항산화능을 측정하는데 주로 이용되고 있다.Free radicals are one of the causes of aging and disease. Free radicals contain at least one pair of unpaired electrons. Atoms and molecules basically share electrons with one another to stabilize it and produce many free radicals, such as free radicals, in the body. These reactive oxygen species cause various adult diseases and aging. Therefore, antioxidant activity can be measured by measuring the ability to remove free radicals. 2,2-diphenyl-1-picryhydrazyl (DPPH), which is used to measure free radical scavenging ability, is dark purple and is itself a radical of nitrogen center and is stabilized by the ununiformization of radical electrons. In addition, it has a relatively stable radical and its absorption peak shows an absorption maximum near 516 nm due to its absorption electrons. When electrons or hydrogen are received, the absorbance decreases around 517 nm and is hard to be oxidized again. Therefore, if the ability to reduce or offset radicals is high, high antioxidant activity and high elimination activity against other radicals such as active oxygen can be expected. Therefore, it is mainly used for measuring the antioxidant ability of a specific substance.
본 발명의 오디 발효물의 항산화 활성으로서 오디음료의 전자공여능을 측정한 결과 표준시료인 비타민 C(대조구)는 97%, 오디 발효물은 87%~92%로 나타나 비타민 C와 동등한 정도의 항산화 활성이 있음을 알 수 있었다.As a result of measuring the electron donating ability of the edible fermented product of the present invention, 97% of vitamin C (control) and 87% to 92% of the fermented product of the standard sample were measured, showing antioxidative activity equivalent to that of vitamin C .
따라서, 항산화 활성이 높은 본 발명의 오디 발효물을 이용하여 오디음료를 제조하는 경우 제조된 오디음료의 항산화 활성도 높을 것임을 유추할 수 있다. Therefore, it can be inferred that the antioxidative activity of the edible beverage prepared by using the edible fermented product of the present invention, which has high antioxidant activity, is high.
<실시예 6> ≪ Example 6 >
오디 Audi 발효물의Fermented 항당뇨Anti-diabetic 효과 분석 Effect analysis
1. 실험방법1. Experimental Method
당뇨유발 시약 Streptozotocin(sigma S-0130)을 이용하여 실험동물(rat 수컷 체중 200±10g)의 복강에 주사하고 일주일 후 쥐(rat)의 안구에서 채혈한 다음, 혈당측정기를 이용하여 혈당 측정 후, 혈당이 고혈당으로 높아진 쥐를 선발하여 실험동물로 이용하였다. 처리방법은 다음과 같다.The mice were injected into the abdominal cavity of experimental animals (male, body weight 200 ± 10g) using streptozotocin (Sigma S-0130), a diabetic inducing reagent, and blood samples were taken from rat eyes one week later. Rats with hyperglycemic hyperglycemia were selected and used as experimental animals. The processing method is as follows.
① 당뇨 유발된 쥐를 선발하여 한 처리구에 20수씩을 배치하였다.① Diabetes induced rats were selected and 20 rats were placed in one treatment.
② 본 발명에 따른 차가버섯 균사체로 발효한 오디 발효물을 급여하지 않는 대조군과, 3ml/1일/수, 2.5ml/1일/수, 2.0ml/1일/수 등의 급여군으로 나누어 총 4처리구로 하였다. 투여 방법은 존데(sonde)를 이용하여 매일 경구 투여하는 것으로 하였다.(2) A control group in which the fermented fermented product of the fermented mushroom mycelium according to the present invention is not fed and the feed group such as 3 ml / day / water, 2.5 ml / day / water, 2.0 ml / 4 treatments. The administration method was to be orally administered daily using sonde.
③ 실험기간은 4주일 간 실시하였으며 실험 개시 전 혈당측정을 비롯하여 일주일 간격으로 총 5회에 걸쳐 경구채혈 하여 혈당을 측정하였다.③ Experimental period was 4 weeks. Blood glucose was measured by oral blood sampling 5 times at intervals of one week including blood glucose measurement before the start of the experiment.
2. 실험 결과2. Experimental results
가. 체중 측정 결과end. Weight measurement results
실험기간 동안 일주일 간격으로 체중을 측정한 결과 본 발명의 오디 발효물 투입군은 처음 혈당치가 높았을 때는 체중이 감소하는 결과를 보였으나 3주일이 경과한 후 거의 정상적으로 증가하는 현상을 보였다. 반면 발효물을 투입하지 않은 대조군의 경우는 체중이 4주 동안 회복의 기미가 보이지 않았다.As a result of measuring the body weight at intervals of one week during the experiment period, the body weight of the first group of the fermented product of the present invention was decreased when the first blood glucose level was high, but it was almost normalized after 3 weeks. In contrast, the control group without fermentation showed no sign of recovery for 4 weeks.
나. 혈당 측정 결과I. Blood glucose measurement result
차가버섯 오디 발효물 투여를 한 경우는 2주일 만에 정상수치의 혈당을 얻을 수 있었다. 그래서 3주간만 투여하고 정상수치가 계속 지속되는가를 알아보기 위하여 1주일 동안은 투여하지 않았다. In the case of fermented mushroom fermented with mushroom, normal blood sugar was obtained in two weeks. So, we did not take it for 1 week to see if it was administered for 3 weeks and the normal value continued.
① 미투여군 : 최초 434.90mg/dl 에서 2주일이 지난 후에는 241.10mg/dl 로 회복의 가능성을 보였으나 4주일 경과 후에는 396.44mg/dl 로 악화되었다.① Maternal army: After 2 weeks from the first 434.90mg / dl, the possibility of recovery to 241.10mg / dl was shown, but it deteriorated to 396.44mg / dl after 4 weeks.
② 2.0ml 투여군 : 최초 314.6mg/dl 에서 2주일이 지난 후에는 144.82mg/dl 로 개선되는 효과를 보였다. 그러나, 3주 지속 투여 후, 4주차의 미투여 기간 경과 후에는 171.27mg/dl 다소 높아지는 경향 보였다.② 2.0ml dose group: The effect was improved to 144.82mg / dl after 2 weeks from the initial 314.6mg / dl. However, after 3 weeks of continuous administration, there was a tendency to slightly increase 171.27 mg / dl after a delay of 4 weeks.
③ 2.5ml 투여군 : 최초 302.6mg/dl 에서 2주일이 지난 후에는 116.4mg/dl 로 정상으로 측정되었다. 또한, 3주 지속 투여 후, 4주차의 미투여 기간 경과 후에도 131.7mg/dl 정상범위의 혈당을 유지하는 경향을 보였다.③ 2.5ml administration group: After the first 302.6mg / dl, it was measured as 116.4mg / dl after 2 weeks. After 3 weeks of continuous administration, the blood glucose level tended to be maintained in the normal range of 131.7 mg / dl even after a delay of 4 weeks.
④ 3.0ml 투여군 : 최초 307.6mg/dl 에서 2주일이 지난 후에는 106.5mg/dl 로 완전히 정상적인 결과를 보였다. 또한, 3주 지속 투여 후, 4주차의 미투여 기간 경과 후에도 121.7mg/dl 정상범위의 혈당을 유지하는 경향을 보였다.④ 3.0 ml administration group: After 2 weeks at the initial 307.6 mg / dl, the result was completely normal at 106.5 mg / dl. After 3 weeks of continuous administration, the blood glucose level tended to be maintained at the normal range of 121.7 mg / dl even after a delay of 4 hours.
<< 실시예Example 7> 7>
상기 실시예 3에서 제조된 차가버섯 균사체로 발효한 발효산물을 이용하여 제조된 본 발명의 오디음료와 발효공정을 거치지 않은 오디를 이용한 음료의 기호도 검사는 교육을 받은 관능검사연구원 20명을 대상으로 오디음료의 향, 신맛, 단맛, 색도(외관), 침전도, 전체적인 기호도에 관하여 식품공전의 방법을 약간 변형하여 5점 평점법에 따른 기호도검사표에 따라 기호도검사법을 시행하였다. The beverage preference test using the fermented product of fermented fermented product prepared in Example 3 and the fermented fermented product of the present invention, which did not pass through the fermentation process, was examined in 20 sensory test laboratories The taste, flavor, taste, color (appearance), sedimentation degree and overall acceptability of the beverage were slightly modified and the preference test method was applied according to the preference score according to the 5-point scale method.
식품고유의 외관, 향 및 맛을 다음의 기호도 채점기준에 따라 채점 결과가 평균 3점 이상이고 1점 항목이 없어야 하고 관능검사의 점수가 3점 이상을 넘어야 제품으로서 적합한 것으로 판정한다. 전체 기호도는 총점수로 계산하여 표기하였다.The appearance, flavor, and taste inherent to the food shall be judged to be suitable as a product if the average score is 3 or more and the score of the sensory test is more than 3 points according to the following criteria. Total likelihood is calculated by total score.
본 발명의 오디음료의 기호도 검사를 실시한 결과 각 공정별로 맛에 있어서는 비슷한 점수였으며, 발효하지 않은 오디를 이용하여 제조된 비교예의 오디음료와 차가버섯 균사체를 접종하여 발효한 오디 발효물을 이용하여 제조된 본 발명의 오디음료는 관능성 결과에서 크게 차이를 보이지 않았다. As a result of the preference test of the beverage of the present invention, it was found that there was a similar score in terms of taste for each process, and that the beverage prepared by using the fermented edible fermented product obtained by inoculation of the comparative example of the non- The inventive ODI beverage did not show a significant difference in the sensory results.
이상으로 본 발명 내용의 특정한 부분을 상세히 기술하였는 바, 당업계의 통상의 지식을 가진 자에게 있어서, 이러한 구체적 기술은 단지 바람직한 실시 양태일 뿐이며, 이에 의해 본 발명의 범위가 제한되는 것이 아닌 점은 명백할 것이다. 따라서 본 발명의 실질적인 범위는 첨부된 청구항 들과 그것들의 등가물에 의하여 정의된다고 할 것이다.While the present invention has been particularly shown and described with reference to specific embodiments thereof, those skilled in the art will appreciate that such specific embodiments are merely preferred embodiments and that the scope of the present invention is not limited thereby. something to do. It is therefore intended that the scope of the invention be defined by the claims appended hereto and their equivalents.
Claims (5)
(b) 상기 오디 분쇄물 대비 물을 10~30 중량% 첨가하여 혼합물을 생성하는 단계;
(c) 상기 혼합물에 차가버섯 균사체 배양액을 접종하고 발효시켜 발효물을 생성하는 단계; 및
(d) 상기 발효물에 부재료를 넣어 혼합하는 단계를 포함하되,
상기 차가버섯 균사체 배양액은 상기 (b)단계의 혼합물 대비 10 중량%로 접종하는 것을 특징으로 하고,
상기 발효시키는 단계는 20~30℃에서 7 일 내지 21 일 동안 발효시키는 것을 특징으로 하며,
상기 부재료는 아로니아, 사과, 감, 블루베리, 블랙베리, 블랙커런트, 복분자, 석류, 포도, 배, 복숭아, 바나나, 딸기, 토마토, 당근, 자두, 매실, 앵두, 다래, 머루, 키위, 참외, 귤, 오렌지, 자몽, 귤, 멜론, 체리, 멜론, 블랙수퍼베리, 망고, 레몬, 및 파인애플로 이루어진 군에서 선택된 하나 이상의 과실 또는 그 농축액인 것을 특징으로 하는,
항당뇨 및 체중감소 효능이 개선된 오디음료의 제조방법.
(a) lyophilizing and pulverizing an oder seed to produce a pulverized product;
(b) adding 10 to 30% by weight of water to the ground product to produce a mixture;
(c) inoculating the mixture with a culture solution of a mushroom mycelium to produce a fermented product; And
(d) mixing the fermentation product with a sub ingredient,
Wherein the culture medium of the mushroom mycelium is inoculated at 10% by weight with respect to the mixture of step (b)
Wherein the fermentation step is characterized by fermentation at 20 to 30 DEG C for 7 to 21 days,
The above ingredients may be selected from the group consisting of Aronia, apple, persimmon, blueberry, blackberry, blackcurrant, bramble, pomegranate, grape, pear, peach, banana, strawberry, tomato, carrot, plum, plum, cherry, Wherein the concentrate is at least one fruit selected from the group consisting of citrus, orange, grapefruit, mandarin, melon, cherry, melon, black super berry, mango, lemon and pineapple.
A method for producing an edible beverage having improved antidiabetic and weight loss efficacy.
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
KR1020160161379A KR101913004B1 (en) | 2016-11-30 | 2016-11-30 | Manufacturing method of fermented mulberry beverage using mycelia of chaga mushroom |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
KR1020160161379A KR101913004B1 (en) | 2016-11-30 | 2016-11-30 | Manufacturing method of fermented mulberry beverage using mycelia of chaga mushroom |
Publications (2)
Publication Number | Publication Date |
---|---|
KR20180061808A KR20180061808A (en) | 2018-06-08 |
KR101913004B1 true KR101913004B1 (en) | 2018-10-29 |
Family
ID=62600564
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
KR1020160161379A KR101913004B1 (en) | 2016-11-30 | 2016-11-30 | Manufacturing method of fermented mulberry beverage using mycelia of chaga mushroom |
Country Status (1)
Country | Link |
---|---|
KR (1) | KR101913004B1 (en) |
Cited By (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
KR20200082294A (en) | 2018-12-28 | 2020-07-08 | 고창군 | Lactobacillus plantarum GBL44 isolated from Elder berry, Isolating method thereof, Method for production of fermented mulberry extract and The fermented mulberry extract thereof |
KR20200082307A (en) | 2018-12-28 | 2020-07-08 | 고창군 | Strain isolated from mulberry, Isolating method thereof, Method for production of fermented mulberry extract and The fermented mulberry extract thereof |
Families Citing this family (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN108851061A (en) * | 2018-07-27 | 2018-11-23 | 辽宁晟启昊天生物医药科技有限公司 | A kind of preparation method rich in anthocyanidin fermentation liquid |
KR102597975B1 (en) * | 2020-07-28 | 2023-12-06 | 농업회사법인 한국상황버섯(주) | FUNCTIONAL BEVERAGE FOR CHILDREN COMPRISING Phellinus linteus EXTRACT IMPROVED ANTIOXIDANT ACTIVITY AND METHOD FOR PREPARING THE SAME |
Citations (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
KR101377586B1 (en) * | 2013-01-29 | 2014-03-25 | 김동명 | Method for producing fermented inonotus obliquus with increased antioxidant activity and total phenolic compounds by the solid-state fermentation |
Family Cites Families (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
KR100663876B1 (en) * | 2005-05-16 | 2007-01-02 | 문상욱 | Culture of mushroom mycellia having physiologically active effect |
KR20130093370A (en) * | 2012-02-14 | 2013-08-22 | 대구가톨릭대학교산학협력단 | Production method of anti-hypertentive, anti-diabetic, and anti-aging dihydroflavonols from mulberry fruits by fermentation |
KR101448544B1 (en) * | 2012-12-18 | 2014-10-13 | (주)유셀네트웍스 | Fermented fruit food and the preparation method thereof |
-
2016
- 2016-11-30 KR KR1020160161379A patent/KR101913004B1/en active IP Right Grant
Patent Citations (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
KR101377586B1 (en) * | 2013-01-29 | 2014-03-25 | 김동명 | Method for producing fermented inonotus obliquus with increased antioxidant activity and total phenolic compounds by the solid-state fermentation |
Cited By (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
KR20200082294A (en) | 2018-12-28 | 2020-07-08 | 고창군 | Lactobacillus plantarum GBL44 isolated from Elder berry, Isolating method thereof, Method for production of fermented mulberry extract and The fermented mulberry extract thereof |
KR20200082307A (en) | 2018-12-28 | 2020-07-08 | 고창군 | Strain isolated from mulberry, Isolating method thereof, Method for production of fermented mulberry extract and The fermented mulberry extract thereof |
Also Published As
Publication number | Publication date |
---|---|
KR20180061808A (en) | 2018-06-08 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
KR101913004B1 (en) | Manufacturing method of fermented mulberry beverage using mycelia of chaga mushroom | |
KR100989869B1 (en) | Composition for dissolving hangover containing fermented bean sprouts juice | |
KR101496359B1 (en) | Method for producing breathing fermented solution of wild plants | |
KR101705547B1 (en) | Composition for antioxidant or anticancer or antidiabete or antimicrobial containing balloon flower extract | |
KR102387371B1 (en) | Fermented Stauntonia hexaphylla with improved antioxidant activity and uses thereof | |
KR101382594B1 (en) | Bokbunja vinegar beverage composition and manufacturing method thereof | |
KR101962570B1 (en) | Improve anti-oxidant beverage composition of containing Aronia fermented product by lactic acid and preparation method of the same | |
KR20040063680A (en) | Functional vinegar containing diet enzyme, herb medicines and functional materials | |
KR101063351B1 (en) | The extracts and fractions of Hippophae rhamnoides L. | |
KR20230129136A (en) | Composition for antibacterial, antioxidant, or anti-inflammatory comprising fermented extracts of Canavalia gladiata leaf as an active ingredient | |
KR101889331B1 (en) | A composition having anti-oxidation, anti-inflammation or anti-bacterial activity comprising Acanthopanax koreanum Nakai stem extracts, fractions thereof or compounds isolated therefrom as an active ingredient | |
KR20230080923A (en) | Method for producing a ferment extract of the centella asiatica and composition for antiocidative comprising the ferment extract of the centella asiatica produced by the same | |
KR20040063695A (en) | Functional feed | |
KR101797843B1 (en) | A composition having anti-inflammation or anti-bacterial activity comprising Acanthopanax koreanum Nakai stem extracts, fractions thereof or compounds isolated therefrom as an active ingredient | |
KR101951080B1 (en) | Functional mulberry extract and manufacturing method thereof | |
CN109568413A (en) | A kind of green plum oral spray and preparation method thereof | |
KR102335590B1 (en) | Method for cultivating Cucurbita moschata with increased functionality using fermented Prunus mume and Cucurbita moschata mixture | |
KR102216618B1 (en) | Fermentation method of lactic acid bacteria using artichoke and its use | |
KR20170137566A (en) | THE MANUFACTURING METHOD OF KOREAN PANAX GINSENG FERMENTATION SOLUTION HAVING INCREASING OF Rg3, Rh1 AND COMPOUND K CONTENT AND ANTIOXIDANT PROPERTIES BY ISOLATED LACTIC ACID BACTERIA | |
KR102149547B1 (en) | Fermented vinegar using unripe apple jin-hong and use thereof | |
KR20160088840A (en) | Composition for prevention or treatment of glutamate toxicity related diseases containing butyrolatone derivatives or pharmaceutically acceptable salts thereof as an active ingredient | |
Dalal et al. | A review: potential of wine production from different fruits | |
KR20040063709A (en) | Functional mixed grain powder | |
CN114259515A (en) | Composition with anti-saccharification effect and application | |
KR20160082003A (en) | Preparing Method for Venegar Using Lees of Ethanol Fermentation with Berries and Venegar Beverage Thereof |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
A201 | Request for examination | ||
E902 | Notification of reason for refusal | ||
E701 | Decision to grant or registration of patent right | ||
GRNT | Written decision to grant |